Position in BHC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,862,709
-$156,217 QoQ
Shares Held
986,351
+6.1% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$4,010
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,170,999 across 30 Drug Manufacturers - Specialty & Generic names. BHC ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in BHC
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,862,709 | 986,351 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,018,926 | 929,431 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,784,254 | 832,267 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,253,130 | 814,439 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,882,289 | 883,227 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $5,679,319 | 877,793 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,811,247 | 845,068 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $31,278,738 | 3,833,179 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,998,099 | 1,147,504 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,945,033 | 1,502,831 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $24,245,228 | 3,023,096 | Shares | Defined | 2024-02-08 | |
| 2023-12-31 | $4,010 | 500 | Put | Defined | 2024-02-08 | |
| 2023-09-30 | $89,322,381 | 10,866,470 | Shares | Defined | 2023-11-01 | |
| 2023-09-30 | $4,110 | 500 | Put | Defined | 2023-11-01 | |
| 2023-06-30 | $1,004,000 | 125,500 | Put | Defined | 2023-08-02 | |
| 2023-06-30 | $120,464,488 | 15,058,061 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $1,016,550 | 125,500 | Put | Defined | 2024-06-13 | |
| 2023-03-31 | $130,835,645 | 16,152,549 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $37,267,377 | 5,934,296 | Shares | Defined | 2023-02-01 | |
| 2022-12-31 | $3,140 | 500 | Put | Defined | 2023-02-01 | |
| 2022-09-30 | $15,456,823 | 2,243,371 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $3,445 | 500 | Put | Defined | 2022-11-10 | |
| 2022-06-30 | $20,497,430 | 2,451,846 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $73,550,606 | 3,218,845 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $93,978,003 | 3,403,767 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $93,978,375 | 3,374,448 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $109,801,931 | 3,744,950 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $204,104,258 | 6,430,506 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $3,786,582 | 119,300 | Put | Defined | 2021-05-13 | |
| 2020-12-31 | $106,281,779 | 5,109,701 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $72,882,752 | 4,690,010 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,237,469 | 4,660,332 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $71,975,891 | 4,643,606 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||